Businesses based on new technology and upscale taste—Microsoft and Amazon.com, Starbucks, and Nordstrom—have infused the Pacific Northwest with wealth and entrepreneurial energy. Although it ...

To say that the biotechnology sector is booming would be a significant understatement. The industry has grown to $1.38 trillion as of 2023 and is projected to balloon to $4.25 trillion by 2033. Given ...

After a promising start to the year, the biotech IPO market picked up steam again late this summer, with notable offerings from companies like Upstream, Septerna and BioAge. But what does this ...

When City Manager Aaron Busch attended his first Biotech International conference as a member of the city’s staff, he found himself repeatedly answering two questions. “We had two main ...

Join us for Open Doors — as we approach the start of a new year, what trends will be impacting the biotech industry in 2025? And how can biotech executives, communications and marketing officers ...

The biggest private biotech funding round of November 2024 went to Metsera, which raised $215 million in series B funding. The company is focused on advancing the next generation of therapies for ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it’s never quite as straightforward to implement as one would like. Converge Bio has ...

Yet, with rapid advancements, biotechnology has finally taken its rightful place as a transformative space, bringing with it the potential to reshape industries, economies, and the very fabric of ...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other biotech ...

Biotechnology stocks are among the most volatile in the market due to their high risk. The outcomes of FDA clinical trials and the effectiveness of their therapies in the real world might cause ...